Fibrolamellar carcinoma (FLC) is a liver cancer that typically affects teenagers and adults under age 40 with healthy livers undamaged by alcohol or viruses. It is thought to occur in about one in five million people in the United States.
Interestingly, Dr. Taran Gujral, an associate professor in the Human Biology Division at the Fred Hutchinson Cancer Center, had never heard of FLC when he arrived at the Hutch seven years ago. Today, because of three factors, this rare cancer consumes a substantial amount of Gujral’s time:
